Keywords: USA, Europe, FDA, EMEA, GlaxoSmithKline, Rotarix, Merck & Co, RotaTeq

US FDA recommends temporary suspension of GlaxoSmithKline’s Rotarix due to extraneous virus

Article | 23 March 2010

Print This

Vaccine news was at the forefront late yesterday, after the US Food and Drug Administration found problems with UK drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in